Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

Prostate cancer is the most common cancer among men ... to assess the impact of these tissue-based genomic tests on risk stratification and treatment decisions for localized prostate cancer.

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

A recent update of this original risk stratification scheme addressed not only recurrence, but also prostate-cancer-specific mortality, in an expanded multicenter database of over 7,000 patients ...

Much of this controversy stemmed from overtreatment of low grade prostate cancer, but this has decreased dramatically with new risk stratification tests and the increased use of active surveillance.

et al "Impact of genomic classifiers on risk stratification and treatment intensity in patients with localized prostate cancer" Ann Intern Med 2025; DOI: 10.7326/ANNALS-24-00700.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review The ...